Contact Information
Available for logged-in reporters only
Newswise (PHILADELPHIA) Bone marrow transplantation is a life-saving therapy for patients with blood cancers like leukemia or lymphoma. However, the depletion of the patients immune system prior to transplantation can put patients at risk of for an infection by a virus called cytomegalovirus (CMV) that can be life threatening in these immune-compromised individuals. Now, researchers have found that a very small subset of anti-viral immune cells, transplanted along with a donors blood stem cells, could be enough to fight and even prevent the disease caused by CMV, in research conducted in mice and published Jan 16th in the Journal of Immunology.
Anywhere between 50-80 percent of adults in the United States are infected with CMV, although the virus is kept under control by a healthy immune system. In patients with weakened immune systems, however, CMV can become reactivated and can cause life-threatening pneumonia, among other symptoms. Current treatment includes antiviral medication, but these are not always well tolerated by patients and they also harm the very cells that bone marrow transplantation aims to replenish.
We know that re-establishment of anti-viral immunity in these patients is critical to fully control cytomegalovirus in bone marrow transplant recipients, says senior author Christopher Snyder, Ph.D., an Assistant Professor of Microbiology and Immunology at Thomas Jefferson University. Our study suggests that, in addition to infusing stem cells that restore the bone marrow, life-long anti-CMV immunity may be rapidly restored by also infusing a subset of anti-viral immune cells that have stem cell-like properties.
Currently, investigators around the world are experimenting with restoring the immune cells responsible for keeping CMV in check by transplanting those specific anti-viral cells from healthy donors a type of immunotherapy. The problem, says Dr. Snyder, is that current methods for selecting anti-viral immune cells may inadvertently limit the ability of those cells to restore life-long immunity.
To date, researchers have focused on developing anti-CMV immunotherapy around the fighter cells called CD8 T effector cells that attack and kill virally-infected host cells. These cells are selected and expanded in the lab to increase their numbers, but this process may limit their life-span and ability to divide.
Dr. Snyder and colleagues found that CMV-specific fighter T cells divided poorly in response to CMV infection or reactivation in mouse models. They hypothesized that a different type of CD8 T cells one that acts more like a stem cell could help control the infection long term. His group showed that a small number of stem-cell like CD8 T cells called memory cells were enough to produce and repeatedly replenish all of the T-effector cells needed to fight the disease. The infused memory cells became major contributors to the recipient anti-viral immune response, persisting for at least 3 months of time and producing the "fighter" cells at a steady stream.
In order to survey whether these cells have counterparts in humans, the researchers compared the genomic fingerprint the profile of genes that were turned up or down of mouse and human memory T cells that were specific for CMV and found that the two had similar profiles. This suggested that human and mouse CMV-specific memory T cells are very similar populations. Therefore infusing similar cells into humans could improve on immunotherapeutic methods for controlling CMV infection," said first author Michael Quinn MD/PhD student in the Department of Microbiology and Immunology at Thomas Jefferson University. This may be a valuable approach to keep the disease from emerging in people.
Our data argue for developing new clinical trials focused specifically on using these T memory cells, in order to determine if it would indeed be better than current therapeutic options, said Dr. Snyder.
Continued here:
A Few Cells Could Prevent Bone Marrow Transplant Infections
- 2013 New Jersey Stem Cell Research Symposium [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Stem Cells and Cloning - New Jersey Right to Life | Prolife [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Regenexx Stem Cell Procedures - New York and New Jersey ... [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Wise Young, M.D., Ph.D., Announced as 12th New Jersey Symposium on Biomaterials Science Dinner Speaker [Last Updated On: September 4th, 2014] [Originally Added On: September 4th, 2014]
- Stem cell medicine - Worldnews.com [Last Updated On: September 6th, 2014] [Originally Added On: September 6th, 2014]
- Stem Cell Therapy Spine and Joint Bergen County New Jersey [Last Updated On: September 27th, 2014] [Originally Added On: September 27th, 2014]
- Sarah heads to Russia in latest battle in war on MS [Last Updated On: October 5th, 2014] [Originally Added On: October 5th, 2014]
- Frequently Asked Questions [FAQs] - Stem Cell Therapy New ... [Last Updated On: October 27th, 2014] [Originally Added On: October 27th, 2014]
- Targeting cancer stem cells: a new therapy to cure cancer ... [Last Updated On: October 29th, 2014] [Originally Added On: October 29th, 2014]
- Dynamic Imaging System Nets Yale Scientist the 2014 STEM CELLS Young Investigator Award [Last Updated On: December 4th, 2014] [Originally Added On: December 4th, 2014]
- Stem Cells from Placenta Show Promise for Treating Heart Failure [Last Updated On: February 12th, 2015] [Originally Added On: February 12th, 2015]
- New Jersey Commission Science and Technology Grants - Stem ... [Last Updated On: February 13th, 2015] [Originally Added On: February 13th, 2015]
- FDA Expands Indication for REVLIMID (Lenalidomide) in Combination with Dexamethasone to Include Patients Newly ... [Last Updated On: February 18th, 2015] [Originally Added On: February 18th, 2015]
- ADDING MULTIMEDIA FDA Expands Indication for REVLIMID (Lenalidomide) in Combination with Dexamethasone to Include ... [Last Updated On: February 19th, 2015] [Originally Added On: February 19th, 2015]
- EAT A PEACH | Beneficial Bacteria [Last Updated On: April 7th, 2015] [Originally Added On: April 7th, 2015]
- Orthopedic Stem Cell Solutions at the Spine & Pain Center ... [Last Updated On: May 8th, 2015] [Originally Added On: May 8th, 2015]
- Research at Rutgers | Rutgers University [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Research Overview | Rutgers Cancer Institute of New Jersey [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- The New Jersey Cord Blood Bank (NJCBB) [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- NJMS Stem Cells - Rutgers New Jersey Medical School [Last Updated On: August 1st, 2016] [Originally Added On: August 1st, 2016]
- New York and New Jersey - Stem Cell Therapy & Platelet ... [Last Updated On: August 1st, 2016] [Originally Added On: August 1st, 2016]
- New results on stem cells ageing - CODIF Recherche et ... [Last Updated On: August 1st, 2016] [Originally Added On: August 1st, 2016]
- Basic Science FAQs - Stem Cell Institute of New Jersey [Last Updated On: October 29th, 2016] [Originally Added On: October 29th, 2016]
- Stem Cell - New Jersey Catholic Conference - Trenton, NJ [Last Updated On: November 23rd, 2016] [Originally Added On: November 23rd, 2016]
- Non-Surgical - The New Jersey Orthopaedic Institute [Last Updated On: November 27th, 2016] [Originally Added On: November 27th, 2016]
- Blood Drive To Honor 2 1/2-year-old Brain Tumor Patient, 4-year-old Lymphoma Patient - TAPinto.net [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- WCT selected to conduct Ph III NurOwn Trial in ALS - OutSourcing-Pharma.com [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- FDA OKs Pfizer drug for rare, fast-killing type of leukemia - New Jersey Herald [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform - TASS [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Stem Cell Center Of NJ - New Jersey Stem Cell Therapy [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Blood Donations Needed During Labor Day Holiday Season - TAPinto.net [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- Taconic, Silverstein to build 150000 s/f life science research center - Real Estate Weekly [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- Blood Donations Needed During Labor Day Holiday Season - TAPinto - TAPinto.net [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- Lab-made "mini organs" helping doctors treat cystic fibrosis - New Jersey Herald [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- Blood Donations Needed Pre and Post Labor Day Holiday - East ... - TAPinto.net [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- National Stem Cell Centers | Stem Cell Therapy in New York ... [Last Updated On: June 20th, 2018] [Originally Added On: June 20th, 2018]
- Regenexx Stem Cell Procedures - New York and New Jersey Metro [Last Updated On: July 15th, 2018] [Originally Added On: July 15th, 2018]
- New York & New Jersey - Stem Cell Therapy & Platelet Rich ... [Last Updated On: July 24th, 2018] [Originally Added On: July 24th, 2018]
- FAQ - Stem Cell Center Of NJ - New Jersey Stem Cell Therapy [Last Updated On: July 29th, 2018] [Originally Added On: July 29th, 2018]
- New Jersey Regenerative Medicine Stem Cell and PRP ... [Last Updated On: September 16th, 2018] [Originally Added On: September 16th, 2018]
- Stem Cells and Cloning | New Jersey Right to Life [Last Updated On: September 16th, 2018] [Originally Added On: September 16th, 2018]
- Cord Blood Storage, NY and NJ | Community Blood Services [Last Updated On: September 20th, 2018] [Originally Added On: September 20th, 2018]
- Stem Cell Therapy in New Jersey | National Stem Cell Centers [Last Updated On: November 13th, 2018] [Originally Added On: November 13th, 2018]
- Do Stem Cells Really Work? - New Jersey Stem Cell Therapy [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Obtain Stem Cell Therapy in New Jersey - Stem Cell Miami [Last Updated On: February 23rd, 2019] [Originally Added On: February 23rd, 2019]
- PTC Therapeutics Inc. (PTCT) and MacroGenics Inc. (NASDAQ:MGNX) Comparing side by side - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Reviewing PTC Therapeutics Inc. (PTCT)'s and Inovio Pharmaceuticals Inc. (NASDAQ:INO)'s results - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Comparing of Osmotica Pharmaceuticals plc (OSMT) and VistaGen Therapeutics Inc. (NASDAQ:VTGN) - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Reviewing Morphic Holding Inc. (MORF)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Reviewing Curis Inc. (CRIS)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Comparing of NewLink Genetics Corporation (NLNK) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Comparison of Merus N.V. (MRUS) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Reviewing ImmunoGen Inc. (IMGN)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly [Last Updated On: November 2nd, 2019] [Originally Added On: November 2nd, 2019]
- On Stage: Allegaeon ready to rock Philly - The Unionville Times [Last Updated On: November 2nd, 2019] [Originally Added On: November 2nd, 2019]
- Reviewing Brainstorm Cell Therapeutics Inc. (BCLI)'s and Pieris Pharmaceuticals Inc. (NASDAQ:PIRS)'s results - MS Wkly [Last Updated On: November 2nd, 2019] [Originally Added On: November 2nd, 2019]
- Contrasting of Brainstorm Cell Therapeutics Inc. (BCLI) and HOOKIPA Pharma Inc. (NASDAQ:HOOK) - MS Wkly [Last Updated On: November 2nd, 2019] [Originally Added On: November 2nd, 2019]
- PTC Therapeutics Inc. (PTCT) and Jounce Therapeutics Inc. (NASDAQ:JNCE) Comparing side by side - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Live Cell Imaging Consumables Market Evolving to a Next-Generation Strategy with New Partnerships, Technologies and Targets by 2023 key players LCC... [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Contrasting of Spero Therapeutics Inc. (SPRO) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Reviewing Capricor Therapeutics Inc. (CAPR)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Reviewing Surface Oncology Inc. (SURF)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Reviewing Magenta Therapeutics Inc. (MGTA)'s and PTC Therapeutics Inc. (NASDAQ:PTCT)'s results - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Celgene to Present New and Updated Data on Key Hematology Pipeline Therapies at American Society of Hematology (ASH) 2019 Annual Meeting - Business... [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Comparing of Rigel Pharmaceuticals Inc. (RIGL) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - The Broch Herald [Last Updated On: November 28th, 2019] [Originally Added On: November 28th, 2019]
- Weekly pick of Neuroscience news from around the world - Brain Tumour Research [Last Updated On: November 30th, 2019] [Originally Added On: November 30th, 2019]
- Stemming the Tide Confronting Anti-Semitism in the 21st Century - The Times of Israel [Last Updated On: January 5th, 2020] [Originally Added On: January 5th, 2020]
- Reviewing Phibro Animal Health (NASDAQ:PAHC) & AgeX Therapeutics (NASDAQ:AGE) - Riverton Roll [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- Horizon to provide access to novel base editing technology - SelectScience [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- John Theurer Cancer Center Announces Appointment of Five New Physicians - Newswise [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- Horizon Discovery to Provide Access to Novel Base Editing Technology - Yahoo Finance [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- Europe's guardian of stem cells and hopes, real and unrealistic - FRANCE 24 [Last Updated On: January 20th, 2020] [Originally Added On: January 20th, 2020]
- TV Guy: A return to history with Auschwitz Untold - New Jersey Herald [Last Updated On: January 27th, 2020] [Originally Added On: January 27th, 2020]
- Musicians and community coming together in Asbury Park to help Point Pleasant 3-year old - Asbury Park Press [Last Updated On: February 12th, 2020] [Originally Added On: February 12th, 2020]
- Are stem cells really the key to making humans live longer? - Wired.co.uk [Last Updated On: February 16th, 2020] [Originally Added On: February 16th, 2020]
- SpaceX set to launch Falcon 9 rocket and Dragon capsule from Cape Canaveral this week - Florida Today [Last Updated On: March 4th, 2020] [Originally Added On: March 4th, 2020]
- CO2 Incubators Market Update: Uncover the Business Strategies of Leaders & Laggards of the Market - 3rd Watch News [Last Updated On: March 6th, 2020] [Originally Added On: March 6th, 2020]
- Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab, DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), for the Treatment... [Last Updated On: May 6th, 2020] [Originally Added On: May 6th, 2020]
- Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma GmbH Enter into Strategic Clinical and Commercial Manufacturing Agreements with... [Last Updated On: May 13th, 2020] [Originally Added On: May 13th, 2020]
- CO2 Incubators Market is Expected to Witness a Steady Growth by 2025 - Farmers Ledger [Last Updated On: June 4th, 2020] [Originally Added On: June 4th, 2020]
- Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX (daratumumab) for the Treatment of Patients with... [Last Updated On: June 10th, 2020] [Originally Added On: June 10th, 2020]